1. Home
  2. USAS vs PHAT Comparison

USAS vs PHAT Comparison

Compare USAS & PHAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Americas Gold and Silver Corporation no par value

USAS

Americas Gold and Silver Corporation no par value

HOLD

Current Price

$5.77

Market Cap

1.1B

ML Signal

HOLD

Logo Phathom Pharmaceuticals Inc.

PHAT

Phathom Pharmaceuticals Inc.

HOLD

Current Price

$14.66

Market Cap

942.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
USAS
PHAT
Founded
1998
2018
Country
Canada
United States
Employees
N/A
N/A
Industry
Metal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
942.6M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
USAS
PHAT
Price
$5.77
$14.66
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
6
Target Price
$4.08
$17.33
AVG Volume (30 Days)
3.5M
809.7K
Earning Date
11-10-2025
10-30-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$104,867,000.00
$147,190,000.00
Revenue This Year
$22.65
$218.59
Revenue Next Year
$69.86
$84.38
P/E Ratio
N/A
N/A
Revenue Growth
N/A
460.30
52 Week Low
$0.87
$2.21
52 Week High
$5.90
$16.45

Technical Indicators

Market Signals
Indicator
USAS
PHAT
Relative Strength Index (RSI) 77.11 52.94
Support Level $4.45 $14.12
Resistance Level $4.81 $16.45
Average True Range (ATR) 0.31 0.74
MACD 0.15 -0.11
Stochastic Oscillator 91.42 21.46

Price Performance

Historical Comparison
USAS
PHAT

About USAS Americas Gold and Silver Corporation no par value

Americas Gold And Silver Corp is a mining company engaged in the acquisition, exploration, development, and production of precious metals mineral properties in Mexico and the United States. The company's primary operating assets, which are also its reporting segments, are the Cosala operations, the Galena Complex, and Relief Canyon. It also holds interests in the San Felipe Development Project located in Sonora, Mexico. The Cosala operations segment, which derives maximum revenue, operates in Mexico, while the Galena Complex and Relief Canyon segments operate in the United States.

About PHAT Phathom Pharmaceuticals Inc.

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

Share on Social Networks: